Karyopharm Therapeutics
KPTI
KPTI
80 hedge funds and large institutions have $345M invested in Karyopharm Therapeutics in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 22 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
-6
Holders Change %
-6.98%
% of All Funds
1.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
31
Reduced
22
Closed
13
Calls
$2.04M
Puts
$790K
Net Calls
+$1.25M
Net Calls Change
+$280K
Top Buyers
| 1 |
BlackRock
New York
|
+$32.1M |
| 2 |
TA
Teachers Advisors
New York
|
+$4.87M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$4.37M |
| 4 |
IHM
Iguana Healthcare Management
New York
|
+$3.53M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$3.46M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$5.81M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.2M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$2.8M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$1.06M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$987K |
